Question · asked by 1 review

HALOPERIDOL vs placebo: Specific behaviour ‐ agitation

Population
terminally ill adults with delirium
Intervention
HALOPERIDOL
Comparison
placebo
Outcome
Specific behaviour ‐ agitation

The review found no eligible studies for this question.

What each review found

Current versions only
No studies found 1 · 50%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 50%Moderate 0 · 0%High 0 · 0%
FindingEffectStudiesGRADE certainty
Summary of findings: haloperidol vs placebo
Agitation within 24 hours · terminally ill adults with delirium
The review found no eligible studies for this question.
Drug therapy for delirium in terminally ill adults (2020) · Cochrane Headline outcomes only
no estimate extractedNot reportedNo studies found
Summary of findings: haloperidol vs placebo
Agitation between 24 and 48 hoursc · terminally ill adults with delirium
Summary of findings: haloperidol showed no clear difference in agitation between 24 and 48 hoursc compared with placebo (low certainty).
Drug therapy for delirium in terminally ill adults (2020) · Cochrane Headline outcomes only
no estimate extracted1 study · 123 participantsLow

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Drug therapy for delirium in terminally ill adults
2020 · Cochrane Headline outcomes only
Not reportedNot extractedNot assessed

The same intervention and outcome, asked in another population or against another comparator.

How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.